931
likes
179
comments
daily view 0
monthly view 0
Live Analytics
Comments 0
We Tried EVERY CGM. This One Is Best in 2026! Analytics Table
Income Estimates for We Tried EVERY CGM. This One Is Best in 2026!
Based on this YouTube video's total view count of 39.9K views and industry-standard rates, the estimated total earning is $28 - $80 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About We Tried EVERY CGM. This One Is Best in 2026!
Explore We Tried EVERY CGM. This One Is Best in 2026! with 39,966 views, 931 likes, and 179 comments. Experience the impact of this video content that has captured audience attention.
Which CGM should you pick in 2026? — we break down every option. In this episode of Diabetes Unlocked, we walk through the full lineup of continuous glucose monitors you’ll see in 2026. We compare the upsides, downsides, who each device is best for, and what we’re actually excited about next year. If you’re choosing a CGM, curious about new launches, or just want the real-world scoop, this episode is for you. 💡 Topics we cover: ✅ Abbott — FreeStyle Libre 3+, Libre 3, Libre 2+ and Libre 2 (who they’re best for and integration differences) ✅ Libre Rio & Lingo — consumer/wellness-focused uses and who should (and shouldn’t) try them ✅ Dexcom — G7, G7 15-day variant, G6, and Dexcom One+ (accuracy, pump compatibility, and real-world pros/cons) ✅ Stelo — Dexcom’s Type 2 diabetes sensor ✅ Medtronic / MiniMed — Guardian 4, Simplera, Simplera Sync, and Instinct (what’s changed and who benefits) ✅ Eversense — implantable options and where they fit in 2026 ✅ Roche — where Accu-Chek is positioned in the CGM space ✅ SiBionics GS1/GS3 — the Chinese option, regulatory notes, and affordability/access questions ✅ Our verdicts: who we’d pick for pumps, tight control, non-insulin users, and wellness tracking ✅ What we’re excited to see in 2026: longer wear, better integration, smarter apps, and lower barriers to access We keep it practical — no hype, just our experiences and straight talk about which CGMs earn their place in the 2026 lineup. 💙 No one-size-fits-all answers — just our experiences and honest opinions. Let’s unlock the realities of diabetes together! 👉 Watch next: Underrated vs. Overrated—Diabetes Tools Edition https://youtu.be/DOteERT8tyU 🎧 Subscribe for more diabetes insights, real talk, and expert tips! https://www.youtube.com/@DiabetesUnlockedPodcast?sub_confirmation=1 📢 Let’s connect! 📷 Follow us on Instagram: https://www.instagram.com/diabetesunlocked/ Timestamps: 00:01:19 FreeStyle Libre 3+ 00:07:09 FreeStyle Libre 3 00:07:54 FreeStyle Libre 2+ 00:11:24 Lingo (US) 00:15:33 Libre Rio (US) 00:18:59 Dexcom G7 00:25:15 Dexcom 15-Day 00:27:54 Dexcom G6 00:31:30 Dexcom One+ (EU) 00:33:46 Dexcom Stelo (US) 00:41:00 Eversense 365 (US) 00:48:30 The future of Eversense 00:51:39 Medtronic Minimed Guardian 4 00:54:24 Medtronic Minimed Simplera 00:58:49 Medtronic Minimed Simplera Sync 1:00:00 Medtronic Minimed Simplera Instinct (US) 1:03:41 Roche - Accu-Chek SmartGuide 1:11:58 Sibionics GS1 1:13:37 Sibionics GS3 #diabetesunlocked #typeonetalks #diabetesstrong
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

